ArticleJournal of ultrasound2026
The ultrasound and contrast-enhanced ultrasound characteristics of IgG4-related cholangitis: compared with cholangiocarcinoma.
Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIgG4-related cholangitis (IgG4-SC) is often difficult to differentiate from cholangiocarcinoma (CCA) due to similar clinical and imaging presentations, yet their management and prognosis differ drastically. Accurate non-invasive distinction remains a significant clinical challenge.
aimThis study aimed to identify and compare the characteristic features of IgG4-SC and CCA on conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) to establish reliable imaging discriminators.
methodsWe retrospectively analyzed clinical and imaging data from 14 patients with IgG4-SC and 26 with CCA. Two blinded physicians independently reviewed US and CEUS images to assess lesion characteristics, bile duct lumen visibility, wall thickening, and enhancement patterns. Statistical comparisons were performed using appropriate tests.
resultsOn conventional US, a preserved bile duct lumen within the thickened segment was significantly more frequent in IgG4-SC (10/14, 71.4%) than in CCA (1/26, 3.8%; P < 0.001). Concomitant lesions in other organs were also more common in IgG4-SC (50% vs. 3.8%, P = 0.001). On CEUS, arterial-phase hyper-enhancement was observed in 95.8% of CCA lesions but only in 50.0% of IgG4-SC lesions (P = 0.009), with the latter showing more variable (hypo-/iso-) enhancement.
conclusionThe combination of a preserved bile duct lumen on conventional US and a lower frequency of arterial hyper-enhancement on CEUS provides key imaging clues to differentiate IgG4-SC from CCA. These features, alongside assessment for other organ involvement, may improve diagnostic confidence and guide appropriate clinical management. However, given the exploratory nature of this small-sample study, these findings require validation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.